HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Precipio, Inc. (PRPO)
3.995  0.825  (26.03%) 08-04 15:23
Open: 2.97 High: 5
Pre.close: 3.17 Low: 2.885
Volume: 27,474,874 Ave vol: 3,305,039
52w High: 8 52w Low: 0.55
MA(50): 1.567 MA(200): 1.229
EPS: -2.618 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.precipiodx.com
Market Cap (M): 58
Shares Out (M): 15
Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or blood-related cancers to oncologists. Its cytogenetics media IV-Cell enables laboratories to arrive at more accurate results; and HemeScreen panel enables hospitals and laboratories to run an important genetic mutation test. It serves oncologists, hospitals, reference laboratories, and pharma and biotech companies. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, such as the Yale School of Medicine and Harvard's Dana-Farber Cancer Institute. The company is based in New Haven, Connecticut.
Technical analysis
Overall: Neutral
MA: Bullish MACD: Bullish
KDJ: Bearish RSI: Bullish
Target 1: 6.25 Target 2: 9.34
Resist 1: 5.35 Resist 2: 8.00
Support 1: 1.06 Support 2: 0.88
Company key metrics
Revenue per Share: 0.7113
Net Income per Share: -2.3253
Cash per Share: 0.1489
Book Value per Share: 2.3186
Price to Sales: 2.7133
Price to Book Value: 0.8324
Earnings Yield: -1.2048
Dividend Yield: 0
Debt to Equity: 0.4775
Debt to Assets: 0.3232
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts
Headline news
Tue, 04 Aug 2020
Precipio (PRPO) Launches Covid-19 Antibody Test in its CLIA laboratory - StreetInsider.com

Tue, 04 Aug 2020
Precipio Launches Covid-19 Antibody Test in its CLIA laboratory - GlobeNewswire

Tue, 04 Aug 2020
Why Buy stock in Precipio, Inc. (PRPO)? - Marketing Sentinel

Tue, 04 Aug 2020
Precipio, Inc., (NASDAQ: PRPO) :: For sober investments this stock should be considered - NasdaqNewsFeed

Mon, 03 Aug 2020
The Forecast Just Changed on Precipio Inc. (NASDAQ:PRPO) - The Oracle Dispatch

Fri, 31 Jul 2020
Precipio Inc (PRPO) Stocks Falls 52.29% Friday; Still Up Over 150% this Week - InvestorsObserver

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.